-
James F. Gero
Chairman of the Board of Directors, Director of Intrusion, Inc., Drew Industries, Inc. and Greenleaf, Inc. -
Mr. Gero became Chairman of Orthofix International N.V. on Jan. 1, 2005, and has been a Director of Orthofix International N.V. since 1998. Mr. Gero became a Director of AME Inc. in 1990. He is a Director of Intrusion, Inc. and Drew Industries Inc. as well as being a private investor.
Holdings: 102,504 shares
View Transactions
Date Type Shares Traded Price Range May 8, 2008 Buy 4,500 37.90 May 7, 2008 Buy 3,000 37.24 May 6, 2008 Buy 7,500 36.17 May 11, 2007 Buy 10,000 47.28 - 47.35 Aug 25, 2006 Buy 8,676 39.50 - 39.69 Aug 18, 2006 Buy 15,224 38.78 Aug 17, 2006 Buy 1,100 38.81 -
Charles W. Federico
Director -
Mr. Federico became a Director of Orthofix International N.V. in October 1996 and was the President of Orthofix Inc. from October 1996 to Jan. 1, 2002. On Jan. 1, 2001, Mr. Federico was appointed President and Chief Executive Officer of Orthofix International N.V. From 1985 to 1996, Mr. Federico was the President of Smith & Nephew Endoscopy (formerly Dyonics, Inc.). From 1981 to 1985, Mr. Federico served as Vice President of Dyonics, initially as Director of Marketing and subsequently as General Manager. Previously, he held management and marketing positions with General Foods Corporation, Air Products Corporation, Puritan Bennett Corporation and LSE Corporation. Effective April 1, 2006, Mr. Federico resigned as President and Chief Executive Officer of Orthofix International N.V. but remains on the Board of Directors.
Member of the Communications Committee
Holdings: 4,325 shares
View Transactions
Date Type Shares Traded Price Range Dec 5, 2006 Sell 43,800 45.00 - 45.20 Dec 5, 2006 Option Execute 43,800 37.76 - 43.04 Aug 31, 2006 Sell 124,900 39.15 - 39.74 Aug 31, 2006 Option Execute 124,900 17.88 - 37.76 Aug 30, 2006 Sell 125,100 39.76 - 39.90 Aug 30, 2006 Option Execute 125,100 17.88 -
Alan W. Milinazzo
Director, Group President and CEO -
Mr. Milinazzo joined Orthofix International in 2005 as Chief Operating Officer and succeeded to the position of CEO the following year. Prior to joining Orthofix, Mr. Milinazzo was Vice President of Medtronic Inc.'s Vascular business, as well as, Vice President and General Manager of Medtronic's Coronary and Peripheral businesses. Prior to his time with Medtronic, Mr. Milinazzo spent 12 years as an executive with Boston Scientific Corporation in numerous roles, including Vice President of Marketing for SCIMED Europe. Mr. Milinazzo brings more than two and a half decades of experience in the management and marketing of medical device businesses, including positions with Aspect Medical Systems and American Hospital Supply. He earned a bachelor's degree, cum laude, at Boston College in 1981.
-
Peter J. Hewett
Director -
Mr. Hewett was appointed Deputy Chairman of the Board of Directors in 2005 and has been a non-executive Director of Orthofix International N.V. since March 1992. He was the Deputy Group Chairman of Orthofix International N.V. between March 1998 and December 2000. Previously, Mr. Hewett served as the Managing Director of Caradon Plc, Chairman of the Engineering Division, Chairman and President of Caradon Inc., Caradon Plc's U.S. subsidiary and a member of the Board of Directors of Caradon Plc of England. In addition, he was responsible for Caradon Plc's worldwide human resources function and the development of its acquisition opportunities.
Member of the Communications Committee
Holdings: 59,800 shares
View Transactions
Date Type Shares Traded Price Range Nov 5, 2007 Automatic Sell 2,875 52.04 - 52.51 Nov 5, 2007 Option Execute 5,275 10.63 Oct 29, 2007 Automatic Sell 5,750 53.02 - 53.40 Oct 29, 2007 Option Execute 10,550 10.63 Oct 22, 2007 Automatic Sell 5,750 51.45 - 51.70 Oct 22, 2007 Option Execute 10,550 10.63 Oct 15, 2007 Automatic Sell 5,750 50.15 - 50.95 Oct 15, 2007 Option Execute 10,550 10.63 Oct 8, 2007 Automatic Sell 5,750 49.72 - 50.01 Oct 8, 2007 Option Execute 10,550 10.63 Oct 1, 2007 Automatic Sell 2,875 47.91 - 49.45 Oct 1, 2007 Option Execute 5,275 10.63 Sep 24, 2007 Automatic Sell 2,875 46.58 - 47.20 Sep 24, 2007 Option Execute 5,275 10.63 Sep 17, 2007 Automatic Sell 2,875 45.47 - 45.51 Sep 17, 2007 Option Execute 2,875 10.63 -
Jerry C. Benjamin
General Partner, Advent Ltd. -
Mr. Benjamin became a non-executive Director of Orthofix International N.V. in March 1992. He has been a General Partner of Advent Venture Partners, a venture capital management firm in London since 1985. In the past, Mr. Benjamin was a Director for a number of private healthcare companies.
Chair of the Audit Committee
Member of the Nominating and Governance Committee
-
Walter P. von Wartburg
Chairman of the Board of Directors, Attorney-at-law and Partner, Law & Life Sciences Consultancy, Switzerland -
Dr. von Wartburg became a non-executive Director of Orthofix International N.V. in June 2004. He is an attorney and has practiced privately in his own law firm in Basel, Switzerland since 1999, specializing in life sciences law. He has also been a professor of administrative law and public health policy at the Saint Gall Graduate School of Economics in Switzerland for 25 years. Previously, he held top management positions with Ciba Pharmaceuticals and Novartis at their headquarters in Basel, Switzerland. In addition, Mr. von Wartburg currently serves as a Director on the board of Nymox Pharmaceutical Corporation.
Member of the Compensation Committee
Chair of the Communications Committee
-
Thomas J. Kester CPA
Retired KPMG LLP audit partner -
Mr. Kester became a non-executive Director of Orthofix International N.V. in August 2004. Mr. Kester retired after 28 years, 18 as an audit partner, from KPMG LLP in 2002. While at KPMG, he served as the lead audit engagement partner for both public and private companies and also served four years on KPMG's National Continuous Improvement Committee. Mr. Kester earned a bachelor of science degree in mechanical engineering from Cornell University and an MBA degree from Harvard University.
Member of the Audit Committee
Chair of the Compensation Committee
Holdings: 4,000 shares
View Transactions
Date Type Shares Traded Price Range May 9, 2008 Buy 2,000 33.01 - 33.19 May 14, 2007 Buy 1,000 47.34 -
Guy Jordan PhD
Director -
Dr. Jordan became a non-executive Director of Orthofix International N.V. in December 2004. Most recently, Dr. Jordan served as a group president at CR Bard, Inc., a medical device company, where he had strategic and operating responsibilities for Bard's global oncology business and functional responsibility for all of Bard's research and development. Dr. Jordan earned a Ph.D. in organic chemistry from Georgetown University as well as an MBA from Fairleigh Dickinson University. He also currently serves on the boards of Specialized Health Products International, Inc., Xillix Technologies Corporation and EsophyX, Inc.
Chair of the Nominating and Governance Committee
Member of the Compensation Committee
-
Kenneth R. Weisshaar
Director -
Mr. Weisshaar became a non-executive Director of Orthofix International N.V. in December 2004. Most recently, Mr. Weisshaar has served as Chief Operating Officer and strategy advisor for Sensatex, Inc. Also, Mr. Weisshaar spent 12 years as a corporate officer at Becton Dickson, a medical device company, where at different times he was responsible for global businesses in medical devices and diagnostic products and served as Chief Financial Officer and Vice President, Strategic Planning. Mr. Weisshaar earned a bachelor of science degree from MIT and an MBA from Harvard University. He currently also serves on the board of Digene Corporation.
Member of the Audit Committee
Member of the Nominating and Governance Committee
Member of the Communications Committee
-
James F. Gero
Chairman of the Board of Directors, Director of Intrusion, Inc., Drew Industries, Inc. and Greenleaf, Inc.
-
Charles W. Federico
Director
-
Alan W. Milinazzo
Director, Group President and CEO
-
Peter J. Hewett
Director
-
Jerry C. Benjamin
General Partner, Advent Ltd.
-
Walter P. von Wartburg
Chairman of the Board of Directors, Attorney-at-law and Partner, Law & Life Sciences Consultancy, Switzerland
-
Thomas J. Kester CPA
Retired KPMG LLP audit partner
-
Guy Jordan PhD
Director
-
Kenneth R. Weisshaar
Director


hide all